Across TCGA patient cohorts, ANKRD30BP2 mutation is significantly associated with the total protein of many other genes, with 16 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible ANKRD30BP2-associated genes across cancer lineages are 14-3-3_beta, G6PD, and GSK-3a-b_pS21_S9. Each is linked with ANKRD30BP2 in more than 1 cancer types. Because this analysis shows association rather than direction, both ANKRD30BP2-to-partner and partner-to-ANKRD30BP2 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (ANKRD30BP2→partner) and Y-score (partner→ANKRD30BP2) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
UCEC	14-3-3_beta →	-0.157	-2.986	.006	.037	3	1
UCEC	G6PD →	-0.410	-3.000	.028	.037	3	1
UCEC	GSK-3a-b_pS21_S9 →	+0.590	+3.000	.016	.037	3	1
UCEC	Shc_pY317 →	-0.216	-3.000	.013	.037	3	1
UCEC	CD31 →	-0.216	-3.000	.011	.037	3	1
UCEC	Di-Ras3 →	-0.287	-2.986	<.001	.035	3	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 16 associations by consensus.

Exploration

ANKRD30BP2 survival (RNA) · tumor vs normal (RNA) · all ANKRD30BP2 data types